HDL as a Biomarker of Rejection in Heart Transplant
Journal Title: Global Journal of Obesity, Diabetes and Metabolic Syndrome - Year 2014, Vol 1, Issue 1
Abstract
Background: One hundred once patients underwent heart transplants due to multiple causes. These patients included 36 females and 65 males whose mean age was 51 years. Objective: To study metabolic and lipid changes after heart transplantation with emphasis on HDL in rejected and non rejected hearts. Methods: The metabolic changes pre and post transplant were analyzed. Results: 1. Body mass index (BMI): 25 ± 4 - 28 ± 5 kg/ m2 (P<0.05) 2. Systolic blood pressure (sBP): 107 ± 17 - 131 ± 20mmHg (P<0.05) 3. Diastolic blood pressure (dBP): 70 ± 13 - 81 ± 10 mmHg(P<0.05) 4. Fasting blood sugar (FBS): 107 ± 37- 117 ± 55 mg%(0.164) (non significant) 5. Cholesterol: 170 ± 55 - 189 ± 32 mg/dl(P<0.05) 6. High density lipoprotein (HDL): 38 ± 16 - 52 ± 17 mg/dl (P<0.05) 7. Low density lipoprotein (LDL): 99 ± 20- 83 ± 15 mg/dl (0.34). 8. Triglycerides: 163 ± 10 -188 ± 12 mg/dl (0.144). Conclusions: The heart transplant patients developed metabolic syndrome (MetS). The elevated HDL levels observed after transplantation are indicative of role of immunologic reaction to chronic rejection processes. The patients who died of rejection (19) exhibited greater elevations in HDL that those who did not (47 ± 22 – 71 ± 40 mg/dl, P<0.05). Seven autopsies were performed and revealed severe atherosclerotic changes in the aorta and coronary arteries that were likely related to dysfunctional HDL. The transplanted hearts were 21 years old. The high levels and persistent elevation of HDL observed in the rejected group can be used as a biomarker of rejection and this will help to change the anti-rejection protocol to try to avoid the rejection of the implanted heart. LDL was found to be a factor in the progressive atherosclerotic process because the level was reduced post transplant.
Authors and Affiliations
González Wilma, Altieri Pablo I, Banchs Héctor, Iravedra Diego, Calderón Rafael, González-Cancel Iván, Gurrea Carmen, Escobales Nelson, Crespo Maria
Study of the Effect of Mobile Indirect Calorimeter on Weight Management
This study investigates the effect of utilizing a personalized resting metabolic rate (RMR) mobile tracker based on indirect calorimetry during a 6-month pilot weight loss intervention. Volunteer subjects were randomized...
Role of Advanced Glycation End Products in the Progression of Diabetes Mellitus
Diabetes Mellitus (DM) has become a world problem that seriously affected quality of life in concerned population; however, studies concerning its etiology and therapeutics are not so satisfactory. Hyperglycemia and oxid...
Nutrigenomics Coupling with other OMICS Platform Enhance Personalized Health Care in Metabolic Disorders
Diabetes is a multifactorial of diseases characterized by high blood glucose levels which occur as a result in the body’s inability to produce and/or use insulin. Both type 1 and 2 diabetes are thought to be complex dise...
Serum Concentrations of Osteocalcin (OC) and Beta-Cross Laps (Beta-CTx) and Insulin Resistance in Morbid Obese Women with and without DM2
Aim: The present study was intended to establish the role of bone in grade III obese women with and without type 2 diabetes mellitus (T2DM). Material & Methods: Serum osteocalcin (OC), Beta Cross-Laps (Beta-CTx), parath...
Breath Acetone as Biomarker for Lipid Oxidation and Early Ketone Detection
Former ketone studies, including ketoacidosis (KAD), fasting ketosis (FK), nutritional ketosis (NK), and exercis-eaffected ketosis have brought great advances to the field of ketones. In the present work, blood, urine an...